Ryanair Holdings Plc. is counting on a rapid rollout of coronavirus vaccines to deliver a late-summer travel surge and help the low-cost carrier recover from an annual loss that could reach 950 million euros ($1.1 billion).
While Easter is “essentially a writeoff,” the passenger tally may rebound to between 50% and 70% of normal levels in the peak months of July through September as more people get the jab, Chief Executive Officer Michael O’Leary said in an interview Monday.
